Showing results (741-750 of 755) with videos related to

Sort By:
Pageof 76
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2011
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistanceJean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, et al.
Iscience|October 27, 2025
Abcb5-deficient mice show a subtle, pleiotropic phenotype indicating a role for this transporter in intermediary metabolismJean-Pierre Gillet, Louise Gerard, Wilfred Vieira, et al.
Plos Medicine|February 4, 2015
The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humansMing Zheng, Haili Zhang, David L Dill, et al.
Scientific Reports|December 18, 2021
Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporterRobert W Robey, Andrea N Robinson, Fatima Ali-Rahmani, et al.
Neurology|July 21, 2010
Rapid disease course in African Americans with multiple sclerosisI Kister, E Chamot, J H Bacon, et al.
Cancer Research Communications|August 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient SamplesYasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, et al.
Cancer Research|March 8, 2012
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumorsSven Rottenberg, Marieke A Vollebergh, Bas de Hoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patientsK H Cowan, J A Moscow, H Huang, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Pageof 76